Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:05 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 577–600 of 2,510 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Shigellosis
Interventions: 240 µg Shigella flexneri 2a Invaplex 50 vaccine, 480 µg Shigella flexneri 2a Invaplex 50 vaccine, 690 Shigella flexneri 2a Invaplex 50 vaccine, Shigella challenge strain; Biological · Other
Lead sponsor: U.S. Army Medical Research and Development Command; Federal
Eligibility: 18 Years to 45 Years
Enrollment: 113 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 2
States / cities: Baltimore, Maryland • Silver Spring, Maryland

Conditions: Oropharyngeal Cancer
Interventions: Radiotherapy fractionation; Radiation
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Cardiac Arrest
Interventions: Protocol for rapid FiO2 optimization; Other
Lead sponsor: Cooper Norcross Health; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 5
States / cities: Indianapolis, Indiana • Boston, Massachusetts • Jackson, Mississippi + 2 more

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Transcranial Magnetic Stimulation (TMS), repetitive transcranial magnetic stimulation; Device
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 55 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Diet, Healthy, Weight Change, Body, Dyslipidemias, Blood Pressure
Interventions: Fasting; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Amyotrophic Lateral Sclerosis, Respiratory Muscle Weakness
Interventions: High Frequency Chest Wall Oscillation, Mechanical insufflation/exsufflation; Device
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 21 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Vascular Access Complication
Interventions: RIVS vascular access, Conventional vascular access; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 5 Years to 90 Years
Enrollment: 175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 3
States / cities: Fremont, California • Jacksonville, Florida • Cleveland, Ohio

Conditions: Genital Herpes
Interventions: acyclovir; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Multiple Sclerosis, RRMS, Relapsing Remitting MS
Interventions: HP 13C pyruvate injection, MRI Scanner; Drug · Device
Lead sponsor: Ari Green; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Phenylketonuria (PKU) and Hyperphenylalaninemia
Interventions: PheCheck, Dried Blood Spot Cards.; Device · Diagnostic Test
Lead sponsor: Aptatek BioSciences, Inc; Industry
Eligibility: 1 Year and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Chicago, Illinois • Boston, Massachusetts

Conditions: PCOS
Interventions: DEXA, Magnetic Resonance (MR) Assessment of the Abdomen, MR assessment of Whole Body Fat, Adipose tissue biopsy, Oral glucose tolerance test; Other · Procedure
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Immune Surveillance
Interventions: Agaricus blazei, Reishi, Turkey Tail, Placebo; Dietary Supplement · Other
Lead sponsor: Natural Immune Systems Inc; Other
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Klamath Falls, Oregon

Conditions: Lethal Means Safety, Brief Intervention, Concern Significant Others
Interventions: The Family Firearms Secure storage Training (FFAST) Intervention, Health and Stress Counseling; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 176 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Healthy Volunteers
Interventions: 30 mg dexlansoprazole capsules manufactured at TOB, 30 mg dexlansoprazole capsules manufactured at TPC, 60 mg dexlansoprazole capsules manufactured at TOB, 60 mg dexlansoprazole capsules manufactured at TPC; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: C.Surgical Procedure; Cardiac
Interventions: Ketamine; Drug
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 1 Day to 6 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Cocaine Use Disorder
Interventions: lorcaserin, Placebo Oral Tablet, Substance use counseling, ACASI, Cocaine metabolites, Ecological Momentary Assessment (EMA), Balloon Analogue Risk Task (BART), Qualitative Exit Interview; Drug · Behavioral · Diagnostic Test
Lead sponsor: Glenn-Milo Santos; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cognitive Dysfunction, Cognitive Impairment, Cognitive Decline, Cognitive Change
Interventions: CAMCI, MoCA, Clinical Adjudication; Device · Diagnostic Test
Lead sponsor: Psychology Software Tools, Inc.; Industry
Eligibility: 60 Years to 95 Years
Enrollment: 773 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 4
States / cities: Indianapolis, Indiana • Sharpsburg, Pennsylvania • Houston, Texas + 1 more

Conditions: Obesity, Overweight
Interventions: Bimagrumab, Tirzepatide, Bimagrumab Placebo, Tirzepatide Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 12
States / cities: Anniston, Alabama • Birmingham, Alabama • Walnut Creek, California + 9 more

Conditions: Acute Ischemic Stroke
Interventions: alfimeprase; Drug
Lead sponsor: ARCA Biopharma, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 17
States / cities: Los Angeles, California • Chicago, Illinois • Des Moines, Iowa + 13 more

Conditions: Diabetes Mellitus, Type 2, Obesity
Interventions: Time restricted feeding (TRF), Daily calorie restriction; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 80 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hypertension
Interventions: Heart Health and Nutrition for Life (HHNL), Self-Measured Blood Pressure; Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 84 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Kidney Failure, Chronic, Renal Dialysis
Interventions: InnAVasc arteriovenous graft surgical implant; Device
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 7
States / cities: San Diego, California • Flint, Michigan • Greenwood, Mississippi + 4 more

Conditions: Surgery, Mobility
Interventions: Ambulation; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 90 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Status Asthmaticus, Asthma
Interventions: Montelukast, sterile water; Drug · Other
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 6 Years to 18 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection

Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers

Reoxygenation After Cardiac Arrest II (REOX II Study)

Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)

Effects of a Daily Time-Restricted Feeding Protocol on Diet Quality

ALS and Airway Clearance (ALSAC) Therapy

Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter

A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation

Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

PheCheck™ Validation Study

Transcriptional and Epigenetic Program of PCOS Women

Clinical Trial: Rapid Immune Modulating Effects

Testing Family Firearm Secure Storage Training (FFAST) to Prevent Suicide

Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

Ketamine Pharmacokinetics in Children Having Heart Surgery

Treatment With Lorcaserin for Cocaine Use: The TLC Study

CAMCI: Advancing the Use of Computerized Screening in Healthcare

A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke

Time Restricted Eating for the Treatment of Type 2 Diabetes

WEAVE NM: Heart Health and Nutrition for Life

Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure

Real-time Location System Feasibility Study

Montelukast With Status Asthmaticus, Ages 6-18